Takaharu Negoro

Title: The Innovative Contributions of Takaharu Negoro

Introduction

Takaharu Negoro is a notable inventor based in Takarazuka, Japan. He has made significant contributions to the field of biotechnology, particularly in the development of antitumor proteins. His work has implications for cancer research and treatment, showcasing the potential of genetic engineering in medicine.

Latest Patents

Takaharu Negoro holds a patent for an antitumor protein gene derived from Streptococcus pyogenes Su. This patent includes plasmids containing the amino acid sequence of the N-terminal region of streptococcal acid glycoprotein (SAGP). His research involved synthesizing DNA probes that are complementary to the SAGP gene. Furthermore, he cloned a chromosomal DNA fragment of S. pyogenes Su, which hybridized with those probes into E. coli. A restriction map of the plasmid DNA harboring the SAGP gene was revealed, leading to the determination of the DNA sequence and amino acid sequence of the SAGP gene.

Career Highlights

Takaharu Negoro is associated with Ohgen Research Laboratories, Ltd., where he continues to advance his research in biotechnology. His innovative work has positioned him as a key figure in the development of therapeutic proteins.

Collaborations

He has collaborated with notable colleagues, including Masaharu Kanaoka and Hideo Agui, contributing to a dynamic research environment that fosters innovation.

Conclusion

Takaharu Negoro's contributions to biotechnology, particularly through his patent on antitumor proteins, highlight the importance of innovation in medical research. His work continues to inspire advancements in cancer treatment and genetic engineering.